We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DKL:NYSEDelek Logistics Partners, L.P. Analysis

Data as of 2026-06-13 - not real-time

$53.02

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Delek Logistics Partners (DKL) is trading at $53.02, comfortably above its 20‑day SMA (51.66) and 50‑day SMA (51.03), with the 200‑day SMA (48.43) providing a clear long‑term upward bias. The RSI of 56.7 and a bullish MACD histogram (+0.22) reinforce a momentum‑friendly environment, while volume is on the rise, suggesting growing trader interest. Valuation metrics look attractive: the forward P/E of 9.6 is well below the industry average of 21.5, and the DCF‑derived fair value of $99.3 implies a substantial upside versus the current price. However, the dividend yield of 8.47% comes with a payout ratio of 141%, flagging sustainability concerns. The balance sheet shows $2.33 B of debt versus negligible cash, a debt‑to‑equity of 0 (due to negative equity) and negative free cash flow of $‑65.3 M, underscoring leverage risk. Recent news reveals a $800 M senior note issuance at 6.875% and a tender offer for 7.125% notes due 2028, which could further strain cash resources.
The stock’s beta of 0.24 and 30‑day volatility of ~30% indicate modest market sensitivity but heightened price swings. Operating margins (13.5%) and ROE (4.4%) are modest, and the negative book value per share (‑$0.38) adds a valuation caveat. Given the bullish technical backdrop, undervalued relative‑price multiples, but weak cash generation and aggressive dividend policy, DKL sits at a crossroads where short‑term upside is plausible but long‑term risk is elevated.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, bullish MACD)
  • Valuation upside relative to DCF and forward P/E
  • Increasing volume supporting momentum

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • High dividend yield offset by unsustainable payout ratio
  • New senior note issuance increasing leverage
  • Stable but modest operating performance

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Negative free cash flow and weak cash position
  • Elevated debt levels and upcoming note maturities
  • Dividend sustainability concerns and negative book value

Key Metrics & Analysis

Financial Health

Revenue Growth19.00%
Profit Margin16.00%
P/E Ratio16.7
ROE439.37%
ROA3.83%
P/B Ratio-140.6
Op. Cash Flow$375.9M
Free Cash Flow$-65278876
Industry P/E21.5

Technical Analysis

TrendBullish
RSI56.7
Support$49.13
Resistance$54.75
MA 20$51.66
MA 50$51.03
MA 200$48.43
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$99.32
Target Price$51.40
Upside/Downside-3.06%
GradeUndervalued
TypeBlend
Dividend Yield8.47%

Risk Assessment

Beta0.24
Volatility29.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.